Investor Presentation MAY 2025 1 Cautionary Note Regarding Forward-Looking Statements Cautionary Statement Under the Private Securities Litigation Reform Act; Non-GAAP Measures This presentation contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Such forward- looking statements include anticipated revenue growth, earnings growth and compound annual growth rate, margin expansion or improvement, anticipated future acquisition behavior, ...

Key Takeaways GLDD, TILE, CPRX and STRL all demonstrate solid net profit margins, reflecting operational strength. All have revised 2025 EPS estimates upward recently, highlighting confidence in their outlooks. All picks hold high Zacks Ranks and strong VGM Scores, supporting their upside potential.Investors focus on businesses that consistently generate profits. The net profit margin is key to assessing profitability. A higher net margin indicates a company's efficiency in converting sales into actual pr ...

Celanese (CE) FY Conference June 05, 2025 11:50 AM ET Speaker0 Thank you and good morning. My name is Dave Begleiter of the U. S. Pembos team here at Deutsche Bank. Next up is the team from Celanese led by Scott Richardson. Scott became CEO January first. He spent over twenty years at Celanese in various roles in Asia and U. S. Driving value and outcomes. So a lot of happiness in Celanese the last couple of years. We'll have Scott make a few brief comments around where they are today. We'll go into the fire ...

Summary of Henry Schein (HSIC) 2025 Conference Call Company Overview - **Company**: Henry Schein, Inc. (HSIC) - **Date of Conference**: May 29, 2025 - **Key Speakers**: Ron South (CFO), Andrea Albertini (CEO, Global Distribution and Technology), Tom Popack (CEO, Henry Schein Products Groups) Key Industry Insights - **Market Recovery**: After a slow January attributed to weather, there was a notable recovery in February and March, with positive trends observed in both dental and medical sectors [2][5][7] - **Regulatory Uncertainty**: The introduction of tariffs and regulatory changes has created uncertainty in the market, affecting customer navigation and supplier dynamics [4] - **Dental and Medical Stability**: The dental market remains stable, while the medical sector saw an uptick due to a late flu season, leading to increased sales of diagnostic kits [5] Core Business Initiatives - **Specialty Products Sales**: The distribution sales force is now selling specialty products, particularly in the endodontic business, which has shown strong market share and momentum [9][10][13] - **Implant Market Growth**: The company is experiencing mid to high single-digit growth in the implant market in Europe, while the U.S. market remains relatively flat due to macroeconomic conditions [20][22] - **Global E-commerce Platform**: A new e-commerce platform was launched in the UK and Ireland, with plans for a broader rollout in the U.S. and Canada in 2026. This initiative aims to enhance customer experience and operational efficiency [25][31] Financial Performance and Projections - **Long-term Growth Goals**: The company aims for 8% to 11% EPS growth, contingent on achieving 6% to 8% top-line growth, which is currently challenged by lower market growth rates in core dental and medical sectors [34][35] - **Restructuring Savings**: A restructuring plan initiated last year is expected to yield annual savings of $75 million to $100 million, contributing positively to the cost base by the end of 2025 [37] - **Technology Segment Growth**: The technology segment is expected to return to high single-digit growth, driven by the transition from on-premise to SaaS models, despite current low single-digit growth rates [44][46] Market Challenges and Opportunities - **DSO Relationships**: The company emphasizes the importance of strategic partnerships with Dental Service Organizations (DSOs) to drive profitability rather than engaging in price competition [56][58] - **Medical Segment Growth**: The medical business is projected to achieve a CAGR of 4% to 7%, with home solutions contributing significantly to this growth [61][62] - **KKR Involvement**: KKR's investment is expected to enhance operational efficiency and revenue enhancement initiatives, although it is still in the early stages of collaboration [63][64] Additional Insights - **Equipment Orders**: There is optimism regarding equipment orders, although macroeconomic concerns may lead to delays in installations and revenue recognition [40][41] - **Customer Experience Focus**: The company is working on improving customer experience through loyalty programs and targeted promotions, particularly for online shoppers [30][28] This summary encapsulates the key points discussed during the Henry Schein conference call, highlighting the company's performance, strategic initiatives, and market outlook.

Investors prefer to invest in businesses that reap profits on a regular basis. To gauge the extent of profits, there is no better metric than the net profit margin.A higher net margin reflects a company’s efficiency in converting sales into actual profits. Greenland Technologies Holding Corporation (GTEC) , Great Lakes Dredge & Dock Corporation (GLDD) , Orion Group Holdings, Inc. (ORN) and Climb Global Solutions, Inc. (CLMB) boast solid net profit margins.Net Profit Margin = Net profit/Sales * 100.In simple ...

I think Meta Platforms, Inc (NASDAQ: META ) is highly undervalued because the market is not recognizing the enormous potential. Meta offers so many bets that could be enormously profitable, plus the cash cow ofMy primary area of concentration will be on identifying companies of exceptional caliber, with a proven ability to reinvest capital for impressive returns. Targeting those with a market capitalization of less than $10 billion, affords ample opportunities for growth. The ideal scenario is for these com ...

Reaffirms 2025 earnings guidance range of $4.00 to $4.20 per share with strong confidence in 4-6% EPS growth rate outlookObtained all rights-of-way for 260-mile electric transmission expansion in Wyoming that will provide long-term cost stability for customers and enable growthServed new all-time peak load at Wyoming Electric, reflecting an increase of nearly 10% over 2024, driven by data center and blockchain growthSeeking $35 million of new annual revenues in Nebraska to continue providing reliable servic ...

Ball (BALL) Q1 2025 Earnings Call May 06, 2025 11:00 AM ET Company Participants Brandon Potthoff - Head of Investor RelationsDaniel Fisher - Chairman & CEOHoward Yu - Executive VP & CFOStefan Diaz - Vice President, Equity ResearchPhilip Ng - Managing DirectorJosh Spector - Executive DirectorGeorge Staphos - Managing DirectorNiccolo Piccini - Equity Research AssociateChristopher Parkinson - Managing Director Conference Call Participants Ghansham Panjabi - Senior Research AnalystAnthony Pettinari - AnalystEdl ...

Group 1 - Cardinal Health Inc. reported third-quarter 2025 adjusted EPS of $2.35, a 13% increase year over year, surpassing the consensus estimate of $2.17 [1] - Sales remained flat at $54.9 billion, missing the consensus of $55.35 billion, while adjusted operating earnings increased by 21% to $807 million [1] - The Pharmaceutical and Specialty Solutions segment's sales were unchanged at $50.6 billion [1] Group 2 - Revenue for the Global Medical Products and Distribution (GMPD) segment rose by 2% to $3.2 billion, driven by volume growth from existing customers [2] - Segment profit increased by 14% to $662 million in the third quarter, supported by brand and specialty products, MSO platforms, and positive generics program performance [6] - The company raised its fiscal year 2025 adjusted EPS guidance from $7.85-$8.00 to $8.05-$8.15, compared to the consensus of $7.96 [3] Group 3 - Cardinal Health anticipates double-digit non-GAAP EPS growth in fiscal 2026 despite evolving macroeconomic conditions [4] - The outlook for the Pharmaceutical and Specialty Solutions segment profit was increased to 11.5% to 12.5% growth, up from a previous range of 10% to 12% [6] - The company expects GMPD segment profit to be consistent with fiscal 2025 segment profit amid macro uncertainty [6] Group 4 - CAH stock is trading 2.30% higher at $144.53 [5] - The company plans to discuss its fiscal 2026 and beyond expectations at its upcoming Investor Day on June 12 [6]

Plexus Corp. (NASDAQ:PLXS) Q2 2025 Earnings Conference Call April 24, 2025 8:30 AM ET Company Participants Shawn Harrison - Vice President, Investor Relations Todd Kelsey - President & Chief Executive Officer Oliver Mihm - Executive Vice President & Chief Operating Officer Pat Jermain - Executive Vice President & Chief Financial Officer Conference Call Participants David Williams – Benchmark Melissa Fairbanks - Raymond James Steven Fox - Fox Advisors LLC Ruben Roy - Stifel Jim Ricchiuti - Needham & Company ...